News & Views
Acquisition maintains Focus on Medical Devices
Apr 30 2021
The Ulkox® and Oleoabrax® products, based on an Olea Europaea leaf extract wound-healing technology, have been acquired by Noventure, specialised in licensing medical devices and food supplements. The medical devices were originally developed by Spanish companies Quesper R&D and Orpea Ibérica, together with the Andalusian Health Service (Servicio Andaluz de Salud, SAS).
Luciano Conde, CEO of Noventure, said: “This agreement will enable us to keep shaping innovative science assets and bring them to markets around the world, and to take steps towards becoming a key player in medical devices for topical applications. This is only the beginning; we have many innovative products that we will be able to bring to patients, thanks to this patented new technology.”
Ulkox and Oleoabrax, the first Olea Europaea-based products for Noventure, are already available for licensing. Certified as Class IIb medical devices, they are indicated for healing skin wounds of full or partial thickness. As amorphous hydrogels, they protect the affected area from infection and boost healing based on four properties: the protective barrier, skin hydration, pH control and oxygen radical scavenging effect.
More information online
Digital Edition
International Labmate Buyers' Guide 2024/25
June 2024
Buyers' Guide featuring: Product Listings & Manufacturers Directory Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters - Digital transformatio...
View all digital editions
Events
Jul 07 2024 Dublin, Ireland
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia